Control of the HIV Infection Dynamics with a Reduced Second Order Model H. Chang and A. Astolfi Department of Electrical and Electronic Engineering Imperial.

Slides:



Advertisements
Similar presentations
Unit 6 Diagnosis & Follow-up of HIV Infection
Advertisements

1 HIV Curative Strategies: Key Research Priorities Deeks S, et al., (2013) Nat Rev Immunol. 12(8):
Progression of HIV Infection Cases Diagnosed in Florida Through 2012 Florida Department of Health HIV/AIDS and Hepatitis Section Division of Disease Control.
Florins A 1, Debacq C 1, Gillet N 1, Jean G 1, Thewis A 1, Schwartz-Cornil I 2, Bonneau M 2, Hay J 3, Asquith B 4, Burny A 1, Kettmann R 1 and Willems.
Protective HLA Class I alleles are associated with reduced immune activation in Primary HIV infection Elizabeth Hamlyn 1, Stephen Hickling 2, Abdel Babiker.
Copyright © 2004 Pearson Education, Inc., publishing as Benjamin Cummings PowerPoint ® Lecture Slide Presentation prepared by Christine L. Case Microbiology.
Current HIV basic science research topics. Toddler "Functionally Cured" of HIV Infection- “the Mississippi Baby” First well-documented case of an HIV.
Preventing HIV/AIDS There is no way to tell just by looking whether a person is infected with HIV. Because people are unaware that they are HIV-positive,
1 Lecture 3: Laboratory Diagnostics in ARV Therapy delivered by Dr. Madisa Mine, Botswana Ministry of Health KITSO AIDS Training Program.
HIV-1 DNA levels after antiretroviral therapy in primary infection predict disease progression: the SPARTAC Trial James Williams 1,2,3, Jacob Hurst 1,2,3,
Persisting long term benefit of genotypic guided treatment in HIV infected patients failing HAART and Importance of Protease Inhibitor plasma levels. Viradapt.
HIV/AIDS Epidemiology Update February 2009 Dr Nigel Dickson Director, AIDS Epidemiology Group Department of Preventive and Social Medicine University of.
Acute HIV Infection Translating Pathogenesis into Opportunity Eric S. Rosenberg, M.D. Associate Professor of Medicine Massachusetts General Hospital Harvard.
Eric S. Rosenberg, M.D. Associate Professor of Medicine Massachusetts General Hospital Harvard Medical School
1 Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
“ Be Human. Value Life.” HIV/AIDS. What is HIV? Human Immunodeficiency Virus Retrovirus- known for long incubation periods, prolonged illness The HIV.
Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection DR. S.K CHATURVEDI DR. KANUPRIYA CHATURVEDI.
INTRODUCTION Evaluation of Outcomes in Patients Starting Antiretroviral Therapy During Hospitalization Leigh E. Efird, PharmD 1, Manish Patel, PharmD 1,
Challenges to replacing CD4 testing with viroloigical monitoring Andrew Hill, Pharmacology Research Laboratories, University of Liverpool, UK World AIDS.
Persistent HIV-1 infection in duodenal mucosa and memory CD8+ T cell differentiation Liliana Belmonte 1 PhD; Alberto Zalar 2 MD; Patricia Baré 1 PhD; Noel.
1 Counseling and HIV Testing HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
Clinical case 19 Lin, I-Yao (Sally). Case 19 Having been confined in the hospital for almost a month due recurrent pneumonia, Mr. XXX, 42 y/o, married,
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System The United Kingdom provides excellent access and quality of.
Microbiology B.E Pruitt & Jane J. Stein AN INTRODUCTION EIGHTH EDITION TORTORA FUNKE CASE Chapter 10, part B Classification of Microorganisms.
AIDS. What is AIDS  Applies to the most advanced stages of HIV infection.  CDC defines AIDS as all HIV infected people who have fewer than 200 CD4 positive.
The case for HIV testing A presentation for the clinical team in your practice.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System The threshold for an ART secondary prevention effect on HIV.
Progression of HIV Infection Cases Diagnosed in Florida Through 2014 Florida Department of Health HIV/AIDS Section Division of Disease Control and Health.
MTN-016 TRAINING Infant HIV Testing Urvi M Parikh, Ph.D. University of Pittsburgh Pittsburgh, PA USA.
Background Appropriate time to start HAART is still debatable 1995: “Time to hit HIV, early and hard” Eradication thought to be possible Early regimens.
Annual Epidemiological Spotlight on HIV in London: 2014 data Field Epidemiology Services PHE Publications gateway number
IAS Members Meeting July 19th 2011 Achievements and learning over the past 30 years: what do we need next? Françoise BARRÉ-SINOUSSI Regulation of Retroviral.
ProgressionOf HIV Infection Cases Diagnosed in Florida Through 2011 Florida Department of Health HIV/AIDS & Hepatitis Program Annual data as of 07/31/2012.
MINNESOTA’S HIV TREATMENT CASCADE April, Introduction.
Antigen-Antibody Interactions: Selected Tests (Contd.)
The Modeling of the HIV Virus. Group Members Peter Phivilay Eric Siegel Seabass < With help from Joe Geddes.
HIV and STI Department The case for HIV testing A presentation for the clinical team in your practice.
WE’RE BACK.... Altering HIV Treatment to Maximize Life Span Denise Tabasco Emma Benn Rachel Epstein Audrey Hucks.
RETROVIRIDAE GENUS: ONCOVIRUS: HTLV-1 and HTLV-2 SPUMAVIRUS LENTIVIRUS: HIV-1 and HIV-2.
Cellular immune control of Human Immunodeficiency Virus (HIV) Dr. Ali Jalil Ali College of pharmacy.
HAART Initiation Within 2 Weeks of Seroconversion Associated With Virologic and Immunologic Benefits Slideset on: Hecht FM, Wang L, Collier A, et al. A.
Date of download: 6/27/2016 From: Influence of Alternative Thresholds for Initiating HIV Treatment on Quality-Adjusted Life Expectancy: A Decision Model.
Kingdome of Saudia Arabia Al-Majmaah University Applied of Medical Science Clinical Virology CLINICAL VIROLOGY MDL 325 Presented by : Mohammad Al- Turaqi.
HIV Human immunodeficiency Enveloped, icosahedral, single stranded linear, RNA It belongs to the Retrovirus family that is.
IMMUNODEFICIENCIES HIV2 324 PHT Dr. Sarah I. Bukhari PhD in Clinical Microbiology Department of Pharmaceutics Office: rd floor
Texas Pediatric Society Electronic Poster Contest
Learning objectives Define HIV treatment goals
COmbining Probable TRAjectories — COPTRA
Ann Intern Med. 2017;167(1):1-7. doi: /M Figure Legend:
Volume 105, Issue 5, Pages (May 1994)
HIV Care Continuum in Manhattan
IMMUNOGLOBULIN STRUCTURE AND FUNCTION
HIV-1 PLASMA VIRAL LOAD IN TREATMENT NAÏVE HIV-1 PATIENTS
Globular Protein Made of amino acid chains
HIV and AIDS.
Immunologic Laboratory Tests
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
HIV در مادران و کودکان.
Influence of hepatitis C and hepatitis G virus co-infection on viral and cellular dynamics in patients infected with human immunodeficiency virus following.
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Expansion of CD7low and CD7negative CD8 T-cell effector subsets in HIV-1 infection: correlation with antigenic load and reversion by antiretroviral treatment.
LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis by Albert Gutierrez,
T. Prazuck, J. E. Malkin, L. Belec, S. Chamaret, C. S le, A. Alcais, C
Diagnostic tests for antibody or antigen
Fig. 1 Effect of preinfection β7Hi CD45RA−CD4+ T cell frequency on HIV acquisition risk in CAPRISA 004 study. Effect of preinfection β7Hi CD45RA−CD4+ T.
HCT-15 HT-29 * Figure S1. Oxaliplatin treatment increases CD44high subpopulations in both HCT-15 and HT-29 cells. Flow.
Association of HIV-1 replication fitness, as measured in a whole-virus parallel infection assay, with ability to control viremia after treatment interruption.
Immunologic and pharmacokinetic studies.
Keep control: Elite and post-treatment controllers
Fig. 3. Association between peak CTL019 expansion and response.
Presentation transcript:

Control of the HIV Infection Dynamics with a Reduced Second Order Model H. Chang and A. Astolfi Department of Electrical and Electronic Engineering Imperial College London, UK

HIV and AIDS The state of “long-term non-progressor” in AIDS and researches for its mathematical model : the Berlin patient (1999), LA times article for “elite control” 6 July 2006, etc. Structured Treatment Interruption (STI) Gradual Reduction of Drug Dose (GRDD) Applications of control theory to the treatment : continuous variation of input, state observation, parameter estimation Introduction

Example of Model Predictive Control (MPC) Zurakowski, Teel, J. of Theoretical Biology (2006)

HIV model Uninfected CD4 T-helper cell (x), infected CD4 T-helper cell (y), helper-independent CTL (z1), CTL precursor (w) and helper-dependent CTL (z2) where is the maximal effect of the drug and the control input u represents the drug dosage.

HIV model

HIV measurements Antibody Test : Indication of HIV antibody (e.g. ELISA, Western Blot) Viral Load Test : (also known as polymerase chain reaction(PCR), bDNA test) Currently detect 50 copies/ml. Some advanced method can detect 5 copies/ml.

HIV measurements Flow Cytometry : Monoclonal antibody with fluorescent markers. can be used to count CD4 T cells, important for the prognosis of AIDS. (Problem) : If we measure levels of unusual cells, the required fluorescent antibody may be costly or unavailable.

Modification of the model

Control Strategy 1 Flow Chart :

Two simulations of Control Strategy 1 Case 1 : T = 4(days)

Two simulations of Control Strategy 1 Case 2 : T = 7(days)

Control Strategy 2

Flow Chart :

a simulation of Control Strategy 2 T = 7(days)

We can obtain viral load test results within about 10 days. Relation between drug intake and input u(t) : pharmacokinetics A different model can be used when u = 1. Prediction of the parameters by interpolation/extrapolation Future Directions